CD3 × CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation

Overview of attention for article published in Cancer Immunology, Immunotherapy, May 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 17 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 13 additional patents.